 Jazz Pharmaceuticals PLC NASDAQ: JAZZ shares are trading higher by 10.5 at 151.00 after the company reported better-than-expected fourth-quarter EPS and sales results. Jazz Pharmaceuticals reported quarterly earnings of 4.21 per share which beat the analyst consensus estimate of. 